Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Bengel

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
European Journal of Heart Failure|October 18, 2018
Empagliflozin directly improves diastolic function in human heart failureSteffen Pabel, Stefan Wagner, Hannah Bollenberg, et al.
Nature Communications|November 16, 2021
Detrimental proarrhythmogenic interaction of Ca<sup>2+</sup>/calmodulin-dependent protein kinase II and Na<sub>V</sub>1.8 in heart failurePhilipp Bengel, Nataliya Dybkova, Petros Tirilomis, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
European Journal of Heart Failure|October 18, 2018
Empagliflozin directly improves diastolic function in human heart failureSteffen Pabel, Stefan Wagner, Hannah Bollenberg, et al.
Nature Communications|November 16, 2021
Detrimental proarrhythmogenic interaction of Ca<sup>2+</sup>/calmodulin-dependent protein kinase II and Na<sub>V</sub>1.8 in heart failurePhilipp Bengel, Nataliya Dybkova, Petros Tirilomis, et al.
Pageof 3